CONFERENCES

      European Crohn’s and Colitis Organisation – Inflammatory Bowel Diseases

      This is an annual conference by European Crohn’s and Colitis Organisation (ECCO) that explores the latest developments in the study and treatment of inflammatory bowel diseases (IBD), with topics ranging from genetics to immunology. The conference is aimed at gastroenterologists, researchers, and other professionals involved in the study and treatment of IBD, and provides a forum for sharing knowledge and collaborating on new approaches to diagnosis and therapy.

      13th Congress of ECCO 2018

      Date

      Feb 14, 2018 - Feb 17, 2018

      Location

      Vienna, Austria

      The theme for this year's Congress is “Science improving patients’ lives,” devoting special attention to discoveries and innovations that can have an impact on disease management.

      PMIScience.com is operated by Philip Morris International for the purpose of publishing and disseminating scientific information about Philip Morris International’s efforts to develop and assess products that have the potential to reduce individual risk and population harm associated with tobacco use. This site is for use by scientists, the public health and regulatory communities, and other stakeholders with an interest in tobacco policy. The purpose of this site is not for advertising or marketing. It is not intended for use by consumers.

      Reduced Risk Products ("RRPs”) is the term we use to refer to products that present, are likely to present, or have the potential to present less risk of harm to smokers who switch to these products versus continuing smoking. PMI has a range of RRPs in various stages of development, scientific assessment and commercialization. Our RRPs are smoke-free products that produce an aerosol that contains far lower quantities of harmful and potentially harmful constituents than found in cigarette smoke.